Active Organics, Inc.

Other

Actitech, L.p.

Actim Organics, Inc

Michael A Bishop

Glen Gillis

Elysiann Bishop

Walter J Smith

Scott J Norton

Steven F Schnittger

John LaBonte

Glen S Gillis

Joseph F McCoy

Methods and compositions for reducing and/or inhibiting inflammation by topical application of dermatocosmetic compositions comprising effective amounts of extracts ofthat have been hydrolyzed by an acid protease, preferably, and thereafter rendered substantially devoid of acid-protease activity.

[object Object]

The present invention provides a system for the sterilization of natural products without negatively effecting the properties of the system having a sterilization chamber; a sample area within the sterilization chamber to hold one or more steam permeable containers; a heater source connected to the sterilization chamber for heating the sterilization chamber to a predetermined temperature; a heater control unit connected to the heater source for controlling the predetermined temperature; a pressure source connected to the sterilization chamber for pressurizing the sterilization chamber to a predetermined pressure; a pressure control unit connected to the pressure source for controlling the predetermined pressure; a steam aperture for supplying steam to the sterilization chamber; a steam control unit connected to the temperature and duration of the steam; and an interface connected to the heater control unit, pressure control unit, and steam control unit.

Apparatus and method for steam disinfection of a powder

One embodiment of an occupant propelled roundabout ('roundabout') may have a body. The roundabout may also have a carrier, which may be rotatably carried by the body and may also have a seat assembly adapted to carry an occupant. In addition, the roundabout may also have a drive mechanism pivotally coupled to the seat assembly such that the drive mechanism may be movable between a deployed position and a retracted position. The drive mechanism may be moved toward the deployed position in response to the occupant operating the drive mechanism. Also, the roundabout may have a biasing member, which may be operably connected between the drive mechanism and the carrier so that the biasing member may move the drive mechanism toward the retracted position.

Occupant propelled roundabout

Topical compositions comprising extracts ofthat are substantially devoid of acid-protease activity and their use in treating dermatologic conditions, including reducing the appearance of signs of skin aging.

Methods and compositions for reducing and/or inhibiting inflammation by topical application of dermatocosmetic compositions comprising effective amounts of extracts ofthat have been hydrolyzed by an acid protease, preferablyand thereafter rendered substantially devoid of acid-protease activity.

A training device, for training emergency personnel to breach a locked door with a blunt force technique. The training device includes a door, a door frame, and a locking mechanism having a latching cylinder with a vertical axis, a latch stop, and at least one heavy-duty spring. The door is held in a closed position by the latching cylinder engaging the latch stop under the strong bias of the spring. The application of a blunt force near the locking mechanism causes the latching cylinder to move slightly away from the latch stop to allow the door to enter an open position.

Training device for simulating the response of a locked door to the application of a blunt force

Methods and compositions for reducing the levels of Advanced Glycation Endproducts (AGE) related proteins in the skin by topical application of dermatocosmetic compositions comprising effective amounts of extracts ofthat have been hydrolyzed by an acid protease, preferably, and thereafter rendered substantially devoid of acid-protease activity.

Novel compositions comprising one or more of an acid protease and an acidic buffer, the acidic buffer comprising an acid and a pharmaceutically or cosmetically acceptable carrier, vehicle or excipient, useful for treating or preventing abnormal biological conditions, diseases or disorders, and/or for improving the texture or appearance of the skin, and/or for enhancing epidermal exfoliation and/or for enhancing epidermal cell renewal and to methods for the use of the compositions. The acid protease comprises one or more proteolytic enzymes which exhibit proteolytic activity at pH values below that of the surface of the skin, i.e., approximately pH 5.5. The acidic buffer comprises at least one acidic buffering component that can reversibly disassociate hydrogen ions and has buffering capacity at pH values below that of the surface of the skin, i.e., approximately pH 5.5. or mixtures thereof with a pharmaceutically or cosmetically acceptable carrier, vehicle or excipient. The buffer is capable of reducing the pH of the surface of the skin to less than pH 5.5 and is susceptible to neutralization by normal epidermal processes. Such types of abnormal biological conditions, diseases or disorders include skin atrophy, i.e., the thinning and/or general degradation of the dermis often characterized by a decrease in collagen and/or elastin as well as decreased number, size and doubling potential of fibroblast cells, and other maladies including, but are not limited to dry skin, severe dry skin, dandruff, acne, keratoses, psoriasis, eczema, skin flakiness, pruritus, age spots, lentigines, melasmas, wrinkles, warts, blemished skin, hyperpigmented skin, hyperkeratotic skin, inflammatory dermatoses, age-related skin changes and skin in need of cleansers.

Combination of acid protease enzymes and acidic buffers and uses thereof

Novel compositions comprising one or more of an acid protease and an acidic buffer, the acidic buffer comprising an acid and a pharmaceutically or cosmetically 5 acceptable carrier, vehicle or excipient, useful for treating or preventing abnormal biological conditions, diseases or disorders, and/or for improving the texture or appearance of the skin, and/or for enhancing epidermal exfoliation and/or for enhancing epidermal cell renewal and to methods for the use of the compositions. The acid protease comprises one or more proteolytic enzymes that exhibit proteolytic activity at pH values below that of the surface of the skin, i.e., approximately pH 5.5. The acidic buffer comprises inorganic and/or organic acids or mixtures thereof with a pharmaceutically or cosmetically acceptable carrier, vehicle or excipient. The buffer is capable of reducing the pH of the surface of the skin to less than pH 5.5 and is susceptible to neutralization by normal epidermal processes.

A firefighter training device, for training a firefighter proper techniques for breaking and clearing a window, using a frame defining a framed space, a plurality of transparent impact resistant panels which are arranged coplanarly to fill the framed space, and a plurality of panel retaining assemblies which selectively hold the panels in position. Once the panels are formed into a window like configuration, the panels are struck, causing one of the panels to break away as the panel retaining assembly releases that panel. Then, the remaining panels are struck to cause those panels to break away and to simulate the proper action of clearing the window after it has been initially broken. Following the exercise, the panels are restored to the frame so that the exercise may be repeated.

Window breaking and clearing technique training device

Novel compositions comprising one or more of an acid protease and an acidic buffer, the acidic buffer comprising an acid and a pharmaceutically or cosmetically acceptable carrier, vehicle or excipient, useful for treating or preventing abnormal biological conditions, diseases or disorders, and/or for improving the texture or appearance of the skin, and/or for enhancing epidermal exfoliation and/or for enhancing epidermal cell renewal and to methods for the use of the compositions. The acid protease comprises one or more proteolytic enzymes which exhibit proteolytic activity at pH values below that of the surface of the skin, i.e., approximately pH 5.5. The acidic buffer comprises inorganic and/or organic acids or mixtures thereof with a pharmaceutically or cosmetically acceptable carrier, vehicle or excipient. The buffer is capable of reducing the pH of the surface of the skin to less than pH 5.5 and is susceptible to neutralization by normal epidermal processes. Such types of abnormal biological conditions, diseases or disorders include skin atrophy, i.e., the thinning and/or general degradation of the dermis often characterized by a decrease in collagen and/or elastin as well as decreased number, size and doubling potential of fibroblast cells, and other maladies including, but are not limited to dry skin, severe dry skin, dandruff, acne, keratoses, psoriasis, eczema, skin flakiness, pruritus, age spots, lentigines, melasmas, wrinkles, warts, blemished skin, hyperpigmented skin, hyperkeratotic skin, inflammatory dermatoses, age-related skin changes and skin in need of cleansers.

Growing community of inventors

Dallas, TX, United States of America

Michael A Bishop